Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population

By Chastek Benjamin  

Journal of Dermatological Treatment, Vol. 24, Iss. 1, 2013-02 ,pp. : 25-33

Informa Healthcare

Access to resources Recommend Favorite

Severe pyoderma gangrenosum unresponsive to etanercept and adalimumab

By Kleinpenning Marloes M.   Langewouters Annechien M. G.   Van De Kerkhof Peter C. M.   Greebe Rens J.  

Journal of Dermatological Treatment, Vol. 22, Iss. 5, 2011-10 ,pp. : 261-265

Informa Healthcare

Access to resources Recommend Favorite

The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial)

By Strohal Robert  

Journal of Dermatological Treatment, Vol. 24, Iss. 3, 2013-06 ,pp. : 169-178

Informa Healthcare

Access to resources Recommend Favorite

ILVEN: Is it Psoriasis? Debate Based on Successful Treatment with Etanercept

By Renner Regina   Colsman Andreas   Sticherling Michael  

Acta Dermato-Venereologica, Vol. 88, Iss. 6, 2008-11 ,pp. : 631-632

Medical Journals Limited

Access to resources Recommend Favorite

Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial

By Shikiar Richard   Heffernan Michael   Langley Richard   Willian Mary   Okun Martin   Revicki Dennis  

Journal of Dermatological Treatment, Vol. 18, Iss. 1, 2007-01 ,pp. : 25-31

Informa Healthcare

Access to resources Recommend Favorite